BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 25, 2019
View Archived Issues
Gold nanoparticles found to improve CRISPR delivery system for gene editing
Read More
DGM1 as a novel biomarker of response to enzastaurin in DLBCL and glioblastoma
Read More
ROCK inhibition suppresses tumorigenesis in resistant CSCs
Read More
Phase I/IIa trial of gB/pp65 CMV immunotherapeutic vaccine in recurrent glioblastoma
Read More
FDA approves sBLA for Botox for pediatric patients with upper limb spasticity
Read More
'Cheap and straightforward' structure predictions
Read More
Results presented from first-in-human study of REGN-3767 against advanced malignancies
Read More
Data reported from phase II study of pembrolizumab for recurrent respiratory papillomatosis
Read More
First-in-human results demonstrate [64Cu]/[67Cu] to be a nearly ideal theranostic pair
Read More
Early clinical results reported from trials of anti-CD32b antagonistic antibody BI-1206
Read More
RSLV-132 moves into phase III for Sjogren syndrome after reduced fatigue seen in phase II
Read More
X-Cutag Therapeutics patents new compounds for cancer
Read More
Lin Bioscience synthesizes tubulin polymerization inhibitors
Read More
Epizyme discloses new KAT inhibitors
Read More
Applied Therapeutics initiates phase I/II study of AT-007 in galactosemia
Read More
Dextenza approved by FDA to treat ocular inflammation following ophthalmic surgery
Read More
FDA approves Vyleesi for hypoactive sexual desire disorder in premenopausal women
Read More
Symdeko obtains FDA approval for cystic fibrosis in children aged 6-11 years
Read More
Talzenna approved in E.U. for germline BRCA-mutated locally advanced or metastatic breast cancer
Read More
Kissei Pharmaceutical identifies new CGRP antagonists
Read More
Bayer initiates phase III trial of aflibercept in retinopathy of prematurity
Read More
Oscotec describes new LRRK2 inhibitors
Read More
Axsome enrolls first patient in phase III GEMINI study of AXS-05 for MDD
Read More
FDA allows Athenex's IND to study pegtomarginase for advanced malignancies
Read More
FDA lifts partial clinical hold on phase III CANOVA trial of venetoclax in multiple myeloma
Read More
FDA clears Minerva's IND for huMNC2-CAR44 for metastatic breast cancer
Read More
FDA issues complete response letter for quizartinib in relapsed/refractory FLT3-ITD AML
Read More
